Reply to In vivo confusion over in vivo conversion
Authors:
Open Access
- 1 February 2022
- journal article
- letter
- Published by Elsevier in Molecular Therapy
- Vol. 30 (3) , 986-987
Abstract
No abstract availableFunding Information
- NIH
This publication has 14 references indexed in Scilit:
- Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s diseaseNature Communications, 2020
- A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron ConversionMolecular Therapy, 2020
- AAV cis -regulatory sequences are correlated with ocular toxicityProceedings of the National Academy of Sciences, 2019
- Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainStem Cell Reports, 2018
- The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal CordCell Reports, 2016
- Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo ReprogrammingStem Cell Reports, 2015
- SOX2 Reprograms Resident Astrocytes into Neural Progenitors in the Adult BrainStem Cell Reports, 2015
- Sox2-Mediated Conversion of NG2 Glia into Induced Neurons in the Injured Adult Cerebral CortexStem Cell Reports, 2014
- In vivo conversion of astrocytes to neurons in the injured adult spinal cordNature Communications, 2014
- In vivo reprogramming of astrocytes to neuroblasts in the adult brainNature Cell Biology, 2013